Weranja K. Ranasinghe, MD, PhD, MBBS

Disclosure information not submitted.

Presentation(s):

• PD04-02: Using genomic and transcriptomic properties to determine androgen response in Ductal Prostate Cancers and determine efficacy of Poly(ADP-ribose) polymerase inhibitors with androgen signalling inhibitors therapy in vitro

  Friday, April 28, 2023
  9:40 AM – 9:50 AM CST